MENU
GILD
AS OF
Nov 14, 01:09 PM (EDT)
Price
$124.75
Change
-$0.45 (-0.36%)
Capitalization
155.33B
88 days until earnings call
Intraday BUY SELL Signals
OUR PRODUCTS
MOBILE APPS
GENERAL INFO
Help
© 2013-2025 All rights reserved. Tickeron Inc.
GILD
Stock ticker: NASDAQ
PRICE
CHANGE
CAPITALIZATION

Gilead Sciences (GILD) Earnings Date & Reports

Gilead Sciences develops and markets therapies to treat and prevent life-threatening infectious diseases, with the core of its portfolio focused on HIV and hepatitis B and C... Show more

Industry: #Biotechnology
A.I. Advisor
published Earnings

GILD is expected to report earnings to fall 21.86% to $1.93 per share on February 10

Gilead Sciences GILD Stock Earnings Reports
Q4'25
Est.
$1.93
Q3'25
Beat
by $0.32
Q2'25
Beat
by $0.05
Q1'25
Beat
by $0.04
Q4'24
Beat
by $0.19
The last earnings report on October 30 showed earnings per share of $2.47, beating the estimate of $2.15. With 1.57M shares outstanding, the current market capitalization sits at 155.33B.
View a ticker or compare two or three
GO
VS
Compare
VS
Compare
GILD
Setup
Setup
Daily Signal:
Description
Gain/Loss:
Interact to see
Advertisement
A.I.Advisor
published price charts
These past five trading days, the stock lost 0.00% with an average daily volume of 0 shares traded.The stock tracked a drawdown of 0% for this period. GILD showed earnings on October 30, 2025. You can read more about the earnings report here.
View AI-Driven Trading for GILD
A.I. Advisor
published General Information

General Information

a developer of therapeutic products and treatments for life threatening diseases

Industry PharmaceuticalsMajor

Profile
Fundamentals
Details
Industry
Biotechnology
Address
333 Lakeside Drive
Phone
+1 650 574-3000
Employees
18000
Web
https://www.gilead.com